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Abstract
Carbon monoxide (CO) inhalation often leads to cardiac dysfunction, dysrhythmias, ischemia, infarction, and death. However, the underlying
mechanism of CO toxicity is poorly understood. We hypothesize that inhaled CO interrupts myocardial oxidative phosphorylation by decreasing
the activity of myocardial cytochrome oxidase (CcOX), the terminal oxidase of the electron transport chain. Male C57Bl6 mice were exposed to
either 1000 ppm (0.1%) CO or air for 3 h. Cardiac ventricles were harvested and mitochondria were isolated. CcOX kinetics and heme aa3 content
were measured. Vmax, Km, and turnover number were determined. Levels of CcOX subunit I message and protein were evaluated.
Carboxyhemoglobin (COHb) levels were measured and tissue hypoxia was assessed with immunohistochemistry for pimonidazole hydrochloride.
CO significantly decreased myocardial CcOX activity and Vmax without altering Km. Heme aa3 content and CcOX I protein levels significantly
decreased following CO exposure while enzyme turnover number and CcOX I mRNA levels remained unchanged. CO exposure increased COHb
levels without evidence of tissue hypoxia as compared to sham and hypoxic controls. Decreased CcOX activity following CO inhalation was
likely due to decreased heme aa3 and CcOX subunit I content. Importantly, myocardial CcOX impairment could underlie CO induced cardiac
dysfunction.
© 2007 Elsevier B.V. All rights reserved.Keywords: Cytochrome oxidase; Carbon monoxide; Heart; Inhibition1. Introduction
Carbon monoxide (CO) is the most common cause of lethal
poisoning worldwide [1]. CO, a colorless, odorless and
nonirritant gas, is responsible for over 10,000 deaths annually
in the United States [2,3]. CO exposure can cause cardiac
dysfunction, dysrhythmias, myocardial ischemia, myocardial
infarction, and cardiac arrest [4,5]. Despite these potentially
fatal consequences, the underlying mechanism of CO induced
myocardial toxicity is poorly understood.
The most widely accepted mechanism of systemic CO
toxicity is tissue hypoxia [1]. Because CO binds avidly and
causes a conformational change in hemoglobin, it can reduce
circulating oxygen content and impair tissue oxygen delivery⁎ Corresponding author. Tel.: +1 914 594 4724.
E-mail address: richard_levy@nymc.edu (R.J. Levy).
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doi:10.1016/j.bbadis.2007.06.002[3]. However, this mechanism does not fully correlate with
clinical response to CO exposure [6]. Thus, other mechanisms
have been proposed. These include direct cellular damage by
CO and binding to cellular proteins such as myoglobin and
cytochrome oxidase [6,7].
Cytochrome oxidase (CcOX) is the terminal enzyme in the
mitochondrial electron transport chain [8]. CcOX subunit I,
encoded by mitochondrial DNA, houses the heme aa3 binuclear
center and is the active site of the enzyme [9]. CcOX catalyzes
the reduction of molecular oxygen to water and couples this
with proton translocation across the inner mitochondrial
membrane [8]. Proton translocation is crucial in maintaining
the motive force used by ATPase synthase to produce ATP [8].
Although prior work has shown that CO is capable of
binding to CcOX, in vivo CcOX inhibition by CO has not
been demonstrated [6]. We hypothesize that CO decreases
myocardial CcOX activity, potentially interrupting oxidative
Fig. 1. Lineweaver–Burk plot of myocardial CcOX kinetic activity. The plot
depicts CcOX kinetic activity following exposure to 1000 ppm CO (closed
squares with solid line) or compressed air (open squares with dashed line). Lines
indicate best-fit linear regression for each data set: x-intercept represents −1/Km;
y-intercept represents 1/Vmax. ⁎pb0.01.
1113K.N. Iheagwara et al. / Biochimica et Biophysica Acta 1772 (2007) 1112–1116phosphorylation and impairing cellular ATP production. Speci-
fically, in the studies detailed here we evaluate the effects of
inhaled CO on the ability of myocardial CcOX to oxidize its
primary substrate, cytochrome c.
2. Materials and methods
2.1. CO exposure
Experiments were approved by the Institutional Animal Care and Use
Committee of The Children's Hospital of Philadelphia, and all animals received
care in compliance with the guidelines of the National Institute of Health. Six to
eight week old male C57Bl/6 mice (Charles River Laboratories, Boston, MA)
were individually placed in an airtight 7-L Plexiglas chamber. Mice were
exposed to 1000 parts per million (0.1%) of CO in air for 3 h. The concentration
of CO was chosen based on prior work [10]. Exposure to 3000 ppm CO was
lethal, causing rapid acidosis, a profound reduction in blood pressure, and
asystole. However, exposure to 1000 ppm CO was non-lethal and well tolerated
resulting in moderate elevations of carboxyhemoglobin. Sham mice were
exposed to compressed air for three h. N=5 per group per experiment.
Following three h of exposure, animals were immediately killed with 50 mg/kg
of intraperitoneal pentobarbital.
2.2. CcOX steady-state kinetic activity
Following euthanasia with intraperitoneal pentobarbital (50mg/kg), the heart
was excised; cardiac ventricles were washed out with injected saline and
immediately placed in iced phosphate buffered saline. Ventricles were
homogenized in H medium (70 mM sucrose, 220 mM mannitol, 2.5 mM
HEPES, pH 7.4 and 2 mM EDTA). Mitochondria were isolated by differential
centrifugation and protein concentration determined [11]. CcOX kinetics were
assayed by themethod of Smith in which the rate of oxidation of ferrocytochrome
c is measured by following the decrease in absorbance at 550 nm [12,13]. Assays
were executed in a 1-mL reaction volume containing 50mMPO4−2 (pH 7.0), 2%
lauryl maltoside, and 1 μg of mitochondrial protein. Ferrocytochrome c was
added at concentrations of 80, 40, 20, 10, 5, and 2 mM to initiate the reaction.
First-order rate constants were calculated from mean values of three to four
measurements at each ferrocytochrome c concentration. Specific activities were
calculated using 21.1 mM−1 cm−1 as the extinction coefficient of ferrocyto-
chrome c at 550 nm and Lineweaver–Burk plots were constructed. Vmax and Km
were determined by nonlinear regression.
2.3. Measurement of mitochondrial heme aa3 content
Total heme content of isolated mitochondria dispersed in 10% lauryl
maltoside was determined using the extinction coefficient of 24 nM−1 cm−1 for
the difference in spectra: reduced (605 nm) minus oxidized (630 nm) [11].
Turnover number (TN), which represents moles of substrate converted to product
per unit time, is calculated by dividing CcOX specific activity by heme aa3
content [11].
2.4. Northern blot hybridization of CcOX subunit I
Total RNA was extracted from cardiac ventricles using the method of
Chomczynski and Sacchi [14]. As previously described, 8 μg of denatured RNA
were resolved by electrophoresis on 1.5% formaldehyde-containing agarose
gels. Gels were transferred to nylon membrane and hybridized against purified,
double-stranded 32P-labeled, CcOX subunit I cDNA probes. Autoradiography
and densitometry were performed, and data were normalized to the density of
the 18S ribosomal subunit.
2.5. Protein immunoblotting
10 μg samples of mitochondrial protein were subjected to SDS-acrylamide
gel electrophoresis and immunoblotting as previously described [12,15]. Blots
were labeled with a primary polyclonal antibody to mouse CcOX subunit I(Molecular Probes, Eugene, OR) and then were exposed to a rabbit antimouse
IgG (Santa Cruz Biotechnology, Santa Cruz, CA). The signal was detected by
enhanced chemiluminescence (ECL; Amersham Pharmacia Biotech, Piscat-
away, NJ) and scanning densitometry was used to measure density.
2.6. Carboxyhemoglobin levels and evaluation for tissue hypoxia
Following injection of intraperitoneal pentobarbital (50 mg/kg) but before
the mice became apneic, 200 μL of blood were obtained via intracardiac
puncture and carboxyhemoglobin (COHb) levels were measured (Rapidlab
1265, Bayer Healthcare).
In a separate cohort of animals, pimonidazole hydrochloride (60 mg/kg)
(Hypoxyprobe-1; Chemicon International Inc., Temucula, CA), a 2-nitroimida-
zole hypoxia marker, was injected into the peritoneal cavity of CO exposed and
sham animals at the end of the 3 h gas exposure. Mice exposed to 100% CO
were used as hypoxic controls. Twenty minutes after injection, animals were
killed with intraperitoneal pentobarbital (50 mg/kg), the heart was excised, and
cardiac ventricles immediately placed in iced 10% formalin. Hearts were fixed in
10% formalin at 4 °C overnight, paraffin embedded, and cut into 6 μM thick
sections. Immunohistochemistry was performed with a primary monoclonal
antibody to pimonidazole (Hypoxyprobe-1Mab1, Chemicon International Inc.,
Temucula, CA) followed by exposure to Texas red horse antimouse IgG (Vector
Laboratories Inc. Burlingame, CA). A separate set of sections were exposed
only to Texas red IgG for control. Fluorescence microscopy at 20× was per-
formed using an inverted DM IRE2 HC fluo TCS 1-B-UV microscope coupled
to a Leica TCS SP2 spectral confocal system/UV) (Leica Nussloch, Germany).
Images were obtained at 596 nm excitation with emission at 620 nm.
2.7. Statistical analysis
Five animals were evaluated per group per experiment. Statistical
significance was determined by using Student's t-test with significance set at
pb0.05. Data are presented as the mean±standard deviation.
3. Results
3.1. CO decreased myocardial CcOX activity
Exposure to 1000 ppm CO significantly reduced myocar-
dial CcOX activity relative to sham exposure as demonstrated
by a significantly increased slope in the Lineweaver–Burk plot
(Fig. 1). CcOX maximum velocity (Vmax) decreased signifi-
cantly to 33±5 μmol cytochrome c·min−1·mg protein−1
following CO exposure compared to 44±8 μmol cytochrome
c·min−1·mg protein−1 following sham exposure (pb0.03). Km,
Fig. 2. Myocardial heme aa3 content. Closed bars=CO exposed mice; Open
bars=sham mice. Data are mean±st dev. ⁎pb0.05.
Fig. 4. Western blot of CcOX I protein. Above: Representative blot from one
group of animals is depicted. CO=CO exposed group; S=sham exposure.
Below: Graphic depiction of normalized signal densities. Closed bars=CO
exposed mice; open bars=sam controls. Data are mean±st dev. Sham values
arbitrarily set to 1. ⁎pb0.005.
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following CO exposure versus 37±15 μmol cytochrome c
following sham exposure).
3.2. CO exposure decreases heme aa3 content
Because CO can bind to the heme binuclear center within the
active site of CcOX, we next measured heme aa3 content in
isolated cardiac mitochondria. Relative to sham controls, CO
exposure induced a significant, 50% decrease in heme aa3 levels
(Fig. 2). However, because both myocardial CcOX activity and
heme content were proportionately reduced following CO
exposure, the calculated turnover number was statistically
unchanged (1353±135 s−1 following CO exposure versus
1227±191 s−1 following sham exposure).
3.3. CO decreases steady-state levels of CcOX subunit I protein
without affecting steady state mRNA levels
CO induced inhibition of CcOX activity could result from a
decrease in the amount enzyme present. Therefore, weFig. 3. Northern blot hybridization of CcOX I. Above: a representative blot from
one group of animals is depicted. CO=CO exposed group; S=sham exposure.
18S=ribosomal subunit. Below: graphic depiction of normalized signal
densities. Closed bars=CO exposed mice; open bars=sham controls. Data are
means±st dev. Values normalized to the density of the 18S ribosomal subunit.
Sham densities arbitrarily set to 1. p=NS.examined the effect of CO on steady-state levels of myocardial
CcOX I mRNA and protein using Northern blot analysis and
immunoblotting, respectively. Following CO exposure, steady-
state levels of CcOX I mRNA were unchanged compared to
sham exposure (Fig. 3). In contrast, steady-state levels of CcOX
I protein decreased by 40% following CO exposure relative to
sham controls (Fig. 4).
3.4. CO exposure (1000 ppm) increases COHb levels without
causing tissue hypoxia
CO may cause cellular damage by binding to hemoglobin,
limiting oxygen delivery and inducing tissue hypoxia. There-
fore, we measured COHb levels following CO and sham
exposure. Exposure to 1000 ppm of CO for 3 h significantly
increased COHb levels to 61±4% compared to 1±1%
following exposure to compressed air (pb0.001). To
determine if this level of CO exposure resulted in cardiac
tissue hypoxia, we injected a cohort of mice with pimonida-
zole hydrochloride, a commonly used hypoxic marker.
Immunohistochemistry of cardiac sections from mice exposed
to 1000 ppm CO and sham controls yielded similar
fluorescence patterns (Fig. 5). These fluorescent patterns,
however, were in stark contrast to the bright fluorescence
noted in sections from hypoxic controls (Fig. 5). These
findings suggest the lack of tissue hypoxia in mice exposed to
1000 ppm CO and are consistent with prior work demonstrat-
ing that CO does not induce tissue hypoxia at COHb levels
below 70% [1].
4. Discussion
In this work we demonstrated that inhaled CO significantly
decreased the activity of myocardial CcOX, the terminal en-
zyme in the respiratory chain. This impairment was associated
with significantly decreased CcOX I protein and heme aa3
content. Because there was no change in the turnover number
of CcOX, it is likely that CO-dependent reduction of CcOX
Fig. 5. Assessment for myocardial tissue hypoxia using immunohistochemistry for pimonidazole hydrochloride. Representative sections from mice exposed to air
(sham), mice exposed to 1000 ppm CO (CO0.1%), and from mice exposed to 100% CO (hypoxic controls, CO100%) are demonstrated. The upper panels represent
sections exposed to primary antibody to pimonidazole and secondary antibody conjugated with Texas red (pim+TR). The lower panels are control sections from the
representative groups exposed only to antibody conjugated with Texas red (TR). Sections were imaged using fluorescence microscopy at 20× with 596 nm excitation
and 620 nm emission. Fluorescence patterns are similar between CO0.1% and normoxic sham controls. These were similar to TR control sections. However, regions of
bright fluorescence are clearly seen in CO100% hypoxic controls.
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content. These changes occurred at moderate COHb levels in
the absence of tissue hypoxia. These results are important
because they suggest a previously unexplored cellular effect of
CO inhalation: CO-induced loss of CcOX activity due to
decreased heme aa3 and CcOX enzyme content. Although the
mechanisms of reduced heme and enzyme content are
unknown it is reasonable to postulate that the resultant decrease
in CcOX activity could reduce aerobic ATP synthesis and
contribute to or cause cellular and organ dysfunction. With
respect to the heart, the effect would be altered cardiac
contractility and relaxation. While no functional data are
presented, these findings suggest that the effects of CO on
cardiac function may be multifactorial and not exclusively
due to the formation of COHb or resultant myocardial
hypoxia [3].
Decreased steady-state levels of CcOX I protein in the
setting of unchanged CcOX I mRNA levels suggests an
abnormality in protein translation, decreased CcOX half life,
or increased enzyme destruction. The latter is a likely
explanation because CO avidly binds to heme groups and
can result in reactive oxygen species production, oxidative
stress, and subsequent protein destruction [16]. Additionally,
it is possible that inhaled CO upregulates myocardial heme
oxygenase (HO), the rate-limiting enzyme in heme catabolism
[2,16]. HO may reduce myocardial heme aa3 content, and, in
concert with CcOX I destruction, could reduce overall CcOX
activity. HO-1 induction and endogenous CO production are
thought to be protective in the heart, alternative mechanisms
of heme destruction during exogenous CO exposure may
exist [17,18]. Because tissue levels of CO during exogenous
exposure far exceed those endogenously produced during
heme turnover, the results reported here are more directly
relevant to the toxic effect of inhaled CO as opposed to thephysiologic or protective effect of endogenous CO [19].
consideration of potential effects of endogenous CO is
warranted.
Endogenous CO is important for cellular homeostasis and
signaling. CO is strikingly similar to another diatomic gas in
this regard: nitric oxide (NO) [20]. Both CO and NO share
similar molecular mass, water solubility, and basal rates of
production [20]. In addition, both are believed to act as second
messengers with similar effects on the cardiovascular system
[20]. Furthermore, CO and NO can bind to heme and
competitively inhibit CcOX [2,21]. This physiologic regulation
of CcOX is important. Notably, NO has been shown to target
intracellular heme [22,23]. In addition, endogenous NO impairs
heme synthesis and enhances heme destruction by increasing
HO activity [23]. Both of these effects lead to loss of cellular
heme [23]. Therefore it is quite possible that CO-induced
reduction of myocardial heme content occurs via similar
mechanisms. Such an effect on heme content and biosynthesis
might represent an important physiologic role for endogenous
CO and NO while excess production or increased tissue levels
following inhalation may lead to pathologically decreased
cellular heme content. Reduced enzyme-bound heme results in
impaired function of a variety of important enzymes such as
catalase, cytochrome P450, and CcOX [23] could have dramatic
effects on cell and organ function. Decreased CcOX activity, as
we have shown, represents just one consequence of inhaled CO.
Effects of endogenous and exogenous CO on heme biosynthesis
and destruction, therefore, are important concepts in need of
further investigation. It is likely that, as with NO, CO-induced
effects on cellular heme are important physiologically. How-
ever, tipping the balance toward excess, as with exogenous
exposure, may lead to reduced heme and resultant enzyme
impairment and represents a previously unexplored mechanism
of CO toxicity.
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